Eventually - Changing the way the world shop events

Organoids and Beyond - Next Generation In Vitro Platforms for Preclinical Drug Discovery

01
Dec

2022

When

Leiden

Netherlands

Where

With the expansion of Oncology and Immuno-Oncology drug development, effective preclinical platforms are required for testing efficacy and safety of new targets.

Why Attend

Organoids and Beyond - Next Generation In Vitro Platforms for Preclinical Drug Discovery

Attend sessions and discussions about in vitro platforms and organoids.

Grow

Understand the key differences between 3D in vitro systems, such as cell lines and patient-derived models including organoids.

Experience

Learn how to select the right 3D in vitro platform for your drug development program based on model features, benefits, and limitations.

Be inspired

Hear from keynote speakers about 3D workflow optimization, new ideas, trends, and innovation.

Similar Events

Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing discovery, preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases.

01 - 01 Dec 2022

In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Andrea Bisso

Associate Director

Gadeta

Anita Seshire

Senior Innovation Manager

Healthcare Business of Merck

Paul Vulto

Chief Executive Officer & co-founder

MIMETAS

Willemijn Vader

CEO

VitroScan

Bram Herpers

Senior Director

Crown Bioscience

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Crown Bioscience

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.

Crown Bioscience

Crown Bioscience, Inc. is a platform technology company providing drug discovery and development services in the areas of Oncology and Inflammation.

Why Attend

Organoids and Beyond - Next Generation In Vitro Platforms for Preclinical Drug Discovery